Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1210.58% is 4495% below its 5-year average of -26.35%, around the middle of its 5-year range (-2393.75%–12.32%).
25.19% below its 12-month average of -966.98%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -207.40%.
OPERATING MARGIN
-1210.58%
OPERATING MARGIN AVG TTM
-966.98%
OPERATING MARGIN AVG 3Y
-546.61%
OPERATING MARGIN AVG 5Y
-26.35%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-25.19%
CURRENT VS 3Y AVG
-121.47%
CURRENT VS 5Y AVG
-4494.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Surrozen, Inc.
Market Cap
$195.80M
Operating Margin
-1210.58%
TTM Avg
-966.98%
3Y Avg
-546.61%
5Y Avg
-26.35%
Market Cap
$192.89M
Operating Margin
-43.20%
TTM Avg
-31.09%
3Y Avg
-61.91%
5Y Avg
-120.41%
Market Cap
$198.84M
Operating Margin
-18.58%
TTM Avg
-22.82%
3Y Avg
-47.54%
5Y Avg
-46.03%
Market Cap
$199.21M
Operating Margin
-3099.93%
TTM Avg
-1606.37%
3Y Avg
-882.98%
5Y Avg
-646.62%
Market Cap
$200.96M
Operating Margin
-692.83%
TTM Avg
-418.51%
3Y Avg
-274.13%
5Y Avg
-339.94%
Market Cap
$190.42M
Operating Margin
0.00%
TTM Avg
-141.78%
3Y Avg
-70.89%
5Y Avg
-47.26%
Market Cap
$189.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$204.95M
Operating Margin
-1601.12%
TTM Avg
-930.37%
3Y Avg
-642.01%
5Y Avg
-2085.93%
Market Cap
$208.31M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Surrozen, Inc. (SRZN) | $195.80M | -1210.58% | -966.98% | -546.61% | -26.35% |
| RxSight, Inc. (RXST)vs › | $192.89M | -43.20% | -31.09% | -61.91% | -120.41% |
| Exagen Inc. (XGN)vs › | $198.84M | -18.58% | -22.82% | -47.54% | -46.03% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $199.21M | -3099.93% | -1606.37% | -882.98% | -646.62% |
| Alector, Inc. (ALEC)vs › | $200.96M | -692.83% | -418.51% | -274.13% | -339.94% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.42M | 0.00% | -141.78% | -70.89% | -47.26% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Whitehawk Therapeutics Inc (WHWK)vs › | $204.95M | -1601.12% | -930.37% | -642.01% | -2085.93% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
84.6%
Operating Margin
-1210.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -207.40% |
| 2026-03-31 | -209.12% |
| 2025-12-31 | -2393.75% |
| 2025-09-30 | -1107.32% |
| 2025-06-30 | -917.29% |
| 2025-03-31 | -971.62% |
| 2024-12-31 | -1311.76% |
| 2024-09-30 | 12.32% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -17.35% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
